A retrospective study based on datas from marketscan commercial and supplemental medicare databases to evaluate the methodological challenges of comparative safety study of abatacept in rheumatoid arthritis patients : real world experience.
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.